[VC-1] Plasma Amyloid Beta and Tau Levels Are Predictors of Post-stroke Cognitive Impairment
Asian countries are the hot spot of the world for dementia patients increase mainly Alzheimer’s disease (AD). However, the issue of Asian AD is the vascular contribution to the classical AD pathology, which is even common in recent AD autopsy. Asian countries have an international consortium to study such vascular component on AD, not only the pure vascular dementia. Therefore this symposium focuses on the vascular contribution to AD phenotype and AD pathology with pivotal speakers from the Vas-Cog Asia representatives.
Dr. Chaur-Jong Hu graduated from Taipei Medical University, Taipei, Taiwan in 1990. He completed the Neurology specialty training in Jen-Ai Hospital, Taipei. Currently he serves as a neurologist and also the vice superintendent in research affairs and the director of the Dementia Center in Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan. He also is a professor at the School of Medicine, College of Medicine and vice superintendent of Taipei Neuroscience Institute, Taipei Medical University.
He has ever studied as a research fellow in the Stroke Center, Washington University School of Medicine, St. Louis, Missouri, USA in 2000. His researches focus on clinical and molecular aspects of neurological diseases, including stroke, dementia and neuro-degeneration-related sleep disorders. Dr. Hu also has extensive experience in clinical trials. He has published over 180 peer-reviewed papers and 2 book chapters. He is also a member of the editorial boards in Acta Neurologica Taiwanica, Journal of Neurodegenerative Diseases, Scientific Reports and Medicine. Dr. Hu now is the President of the Taiwan Dementia Society since 2018. He is also a fellow of the American Heart Association (FAHA).
Abstract password authentication.
Password is written on a pocket program and name badge.